精品人妻无码一区二区三区软件 ,麻豆亚洲AV成人无码久久精品,成人欧美一区二区三区视频,免费av毛片不卡无码

您現(xiàn)在的位置是:首頁SCI期刊Human Gene Therapy Clinical Development
Human Gene Therapy Clinical Development

Human Gene Therapy Clinical Development SCIE

2324-8637

醫(yī)學(xué)

No

HUM GENE THER CL DEV

0

20

UNITED STATES

http://online.liebertpub.com/humc

2.778影響因子

危重病醫(yī)學(xué)小學(xué)科

月期刊平臺服務(wù)過的文章錄用時(shí)間為1-3個(gè)月,依據(jù)20年經(jīng)驗(yàn),經(jīng)月期刊專家預(yù)審?fù)ㄟ^后的文章,投稿通過率100%以上!
SCI三劍客

中文簡介

《人類基因治療》是一本涵蓋基因治療各個(gè)方面的多學(xué)科雜志。該雜志通過提供最新的研究和技術(shù)突破,對DNA、RNA和細(xì)胞療法進(jìn)行了深入報(bào)道。人類基因治療為科學(xué)和臨床信息提供了一個(gè)中心論壇,包括倫理、法律、監(jiān)管、社會和商業(yè)問題,使治療程序的進(jìn)步和進(jìn)步能夠改善患者的結(jié)果,并最終治愈疾病。該期刊分為三個(gè)部分。人類基因療法是其旗艦,每年出版12期?!禜GT Methods》是一本雙月刊,主要研究基因治療在產(chǎn)品檢測和開發(fā)中的應(yīng)用。HGT臨床發(fā)展是一份季刊,作為發(fā)布與細(xì)胞和基因治療產(chǎn)品的監(jiān)管審查和商業(yè)開發(fā)相關(guān)的數(shù)據(jù)的場所。完整的覆蓋范圍包括:向量發(fā)展的改善運(yùn)載系統(tǒng)細(xì)胞療法小型核酸療法,包括RNAi臨床試驗(yàn)和動物模型臨床協(xié)議臨床前動物和體外研究評估用于支持臨床應(yīng)用的基因和細(xì)胞治療產(chǎn)品的安全性臨床試驗(yàn),包括結(jié)果證實(shí)性或陰性的臨床試驗(yàn)與基因和細(xì)胞治療產(chǎn)品的商業(yè)開發(fā)相關(guān)的熱點(diǎn)問題《人類基因療法》被美國特殊圖書館協(xié)會生物醫(yī)學(xué)與生命科學(xué)部評選為近100年來生物學(xué)和醫(yī)學(xué)領(lǐng)域最具影響力的期刊之一。人類基因治療、HGT方法和HGT臨床開發(fā)由麻省大學(xué)醫(yī)學(xué)院醫(yī)學(xué)博士特倫斯·r·弗洛特主編;Deput歐洲編輯Nathalie Cartier,醫(yī)學(xué)博士,INSERM,和Thierry VandenDriessche,博士,布魯塞爾自由大學(xué)(VUB);美國佛羅里達(dá)大學(xué)醫(yī)學(xué)院鮑威爾基因治療中心副編輯Barry J. Byrne醫(yī)學(xué)博士,斯坦福大學(xué)醫(yī)學(xué)院Mark A. Kay醫(yī)學(xué)博士;人類基因治療編輯高廣平,麻省大學(xué)醫(yī)學(xué)院博士;方法編輯Hildegard Buning,博士,漢諾威醫(yī)學(xué)院;臨床發(fā)展編輯James M. Wilson,醫(yī)學(xué)博士,賓夕法尼亞大學(xué)醫(yī)學(xué)院,基因治療項(xiàng)目;以及其他主要調(diào)查人員。查看整個(gè)編輯委員會。觀眾:遺傳學(xué)家、醫(yī)學(xué)遺傳學(xué)家、分子生物學(xué)家、病毒學(xué)家、實(shí)驗(yàn)研究人員、實(shí)驗(yàn)醫(yī)學(xué)專家等。人類基因治療和HGT方法提供“即時(shí)在線”出版后72小時(shí)接受

http://www.liebertpub.com/forauthors/human-gene-therapy/19/

英文簡介

Human Gene Therapy is the premier, multidisciplinary journal covering all aspects of gene therapy. The Journal publishes in-depth coverage of DNA, RNA, and cell therapies by delivering the latest breakthroughs in research and technologies. Human Gene Therapy provides a central forum for scientific and clinical information, including ethical, legal, regulatory, social, and commercial issues, which enables the advancement and progress of therapeutic procedures leading to improved patient outcomes, and ultimately, to curing diseases.The Journal is divided into three parts. Human Gene Therapy, the flagship, is published 12 times per year. HGT Methods, a bimonthly journal, focuses on the applications of gene therapy to product testing and development. HGT Clinical Development, a quarterly journal, serves as a venue for publishing data relevant to the regulatory review and commercial development of cell and gene therapy products.Complete coverage includes: Improvements in vector developments Delivery systems Cell therapy Small nucleic acid therapeutics, including RNAi Clinical trials and animal models Clinical protocols Pre-clinical animal and in vitro studies to assess the safety of gene and cell therapy products used to support clinical applications Clinical trials including those in which the results are confirmatory or negative Topical issues related to the commercial development of gene and cell therapy productsHuman Gene Therapy was voted one of the most influential journals in Biology and Medicine over the last 100 years by the Biomedical & Life Sciences Division of the Special Libraries Association.Human Gene Therapy, HGT Methods, and HGT Clinical Development are under the editorial leadership of Editor-in-Chief Terence R. Flotte, MD, University of Massachusetts Medical School; Deput Editors Europe Nathalie Cartier, MD, INSERM, and Thierry VandenDriessche, PhD, Free University of Brussels (VUB); Deputy Editors U.S. Barry J. Byrne, MD, PhD, Powell Gene Therapy Center, University of Florida, College of Medicine and Mark A. Kay, MD, PhD, Stanford University School of Medicine; Human Gene Therapy Editor Guangping Gao, PhD, University of Massachusetts Medical School; Methods Editor Hildegard Büning, PhD, Hannover Medical School; Clinical Development Editor James M. Wilson, MD, PhD, University of Pennsylvania School of Medicine, Gene Therapy Program; and other leading investigators. View the entire editorial board.Audience: Geneticists, medical geneticists, molecular biologists, virologists, experimental researchers, and experimental medicine specialists, among others.Human Gene Therapy and HGT Methods provide “Instant Online” publication 72 hours after acceptance

SCI服務(wù)流程
服務(wù)流程
常見問題
Q&A
1:Frontiers in Neuroanatomy 創(chuàng)刊于2007年,目前的影響因子是2.923,根據(jù)網(wǎng)友評價(jià)審稿速度大概是>12周,或約稿。 英文簡介: Fr
Frontiers in Neuroinformatics是SCI3區(qū)期刊。 Frontiers in Neuroinformatics期刊涉及的研究方向?yàn)獒t(yī)學(xué)領(lǐng)域。 關(guān)于《Frontiers in Neuroinformati
1、《ARAB GULF JOURNAL OF SCIENTIFIC RESEARCH》的 出版地是BAHRAIN ,出版周期是Quarterly,根據(jù)網(wǎng)友評價(jià)審稿速度大概是>12周,或約
在學(xué)術(shù)研究領(lǐng)域,英文論文的撰寫、潤色和翻譯往往是許多研究者的難題。今天在這里為大家講講 如何高效快速的對SCI/EI

影響因子趨勢圖

SCI服務(wù)明細(xì)

醫(yī)學(xué)方向的SCI期刊推薦
R&J
大類學(xué)科同領(lǐng)域優(yōu)質(zhì)期刊 大類學(xué)科 小類學(xué)科 影響因子 分區(qū) ISSN
AMERICAN JOURNAL OF CRITICAL CARE 醫(yī)學(xué) 危重病醫(yī)學(xué) 2.063 N/A 1062-3264
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 醫(yī)學(xué) 危重病醫(yī)學(xué) 16.494 N/A 1073-449X
BURNS 醫(yī)學(xué) 危重病醫(yī)學(xué) 2.247 4區(qū) 0305-4179
CHEST 醫(yī)學(xué) 危重病醫(yī)學(xué) 9.657 1區(qū) 0012-3692
CRITICAL CARE 醫(yī)學(xué) 危重病醫(yī)學(xué) 6.959 2區(qū) 1466-609X
CRITICAL CARE CLINICS 醫(yī)學(xué) 危重病醫(yī)學(xué) 2.744 N/A 0749-0704
CRITICAL CARE MEDICINE 醫(yī)學(xué) 危重病醫(yī)學(xué) 6.971 2區(qū) 0090-3493
Critical Care Nurse 醫(yī)學(xué) 危重病醫(yī)學(xué) 1.291 N/A 0279-5442
Current Opinion in Critical Care 醫(yī)學(xué) 危重病醫(yī)學(xué) 2.54 N/A 1070-5295
INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED 醫(yī)學(xué) 危重病醫(yī)學(xué) 1.834 N/A 0020-1383
醫(yī)學(xué)職稱有哪些? 醫(yī)學(xué)職稱可分為初級職稱、中級職稱、高級職稱又分為副高和正高,所對應(yīng)的職稱稱呼為醫(yī)士、醫(yī)師/住...
教師評高級職稱,專著是一項(xiàng)重要的評價(jià)指標(biāo),能夠全面展示個(gè)人的學(xué)術(shù)水平和研究成果,還能為評職稱提供有力的支持...
不少相關(guān)醫(yī)學(xué)領(lǐng)域的醫(yī)學(xué)生在有發(fā)文需求時(shí),而選擇期刊上苦惱不已,其實(shí)也不必過于憂慮,根據(jù)自身方向以及具體情況...
2025年醫(yī)學(xué)生畢業(yè)季和職稱評審來臨,正在準(zhǔn)備畢業(yè)和職稱評審材料的你,一定要確定好適合發(fā)表的畢業(yè)黨和晉升和留學(xué)的...
水刊指的是哪些發(fā)文量大、審稿速度快、接受率較高的期刊。不同專業(yè)領(lǐng)域中都有水刊,醫(yī)學(xué)領(lǐng)域也不例外。這些期刊可...
在危重病醫(yī)學(xué)這一關(guān)鍵醫(yī)療領(lǐng)域中,科學(xué)論文選擇合適的sci期刊分析研究成果,提升以來實(shí)踐水平是非常重要的。今天在...
sci所收錄的醫(yī)學(xué)領(lǐng)域涉及到很多種類,其中就包括危重病醫(yī)學(xué),也是有不少該方向的醫(yī)學(xué)人員發(fā)表論文,而且對期刊的選...

發(fā)現(xiàn)心儀選題請?zhí)顔?/b>

獲取發(fā)表周期短、審稿速度快容易錄用的期刊